{"id":"https://openalex.org/W1790779685","doi":"https://doi.org/10.1016/j.tiv.2015.09.019","title":"Minimizing DILI risk in drug discovery \u2014 A screening tool for drug candidates","display_name":"Minimizing DILI risk in drug discovery \u2014 A screening tool for drug candidates","alternate_titles":[],"publication_year":2015,"publication_date":"2015-09-25","ids":{"openalex":"https://openalex.org/W1790779685","doi":"https://doi.org/10.1016/j.tiv.2015.09.019","mag":"1790779685","pmid":"https://pubmed.ncbi.nlm.nih.gov/26407524"},"language":"en","primary_location":{"id":"doi:10.1016/j.tiv.2015.09.019","doi":"https://doi.org/10.1016/j.tiv.2015.09.019","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.tiv.2015.09.019","pdf_url":null,"source":{"id":"https://openalex.org/S39580544","display_name":"Toxicology in Vitro","issn_l":"0887-2333","issn":["0887-2333","1879-3177"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology in Vitro","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1790779685"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102785126","display_name":"Simone Schadt","orcid":"https://orcid.org/0000-0001-5932-9423","observed_orcids":["https://orcid.org/0000-0001-5932-9423"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"S. Schadt","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: simone.schadt@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: simone.schadt@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112584647","display_name":"Silke Simon","orcid":"https://orcid.org/0009-0008-2078-3635","observed_orcids":["https://orcid.org/0009-0008-2078-3635"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"S. Simon","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: silke.simon@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: silke.simon@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087339920","display_name":"Stefan Kustermann","orcid":"https://orcid.org/0000-0001-7273-9849","observed_orcids":["https://orcid.org/0000-0001-7273-9849"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"S. Kustermann","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: stefan.kustermann@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":"https://orcid.org/0000-0001-7273-9849","affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: stefan.kustermann@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050962059","display_name":"Franziska Boess","orcid":"https://orcid.org/0000-0002-3886-8193","observed_orcids":["https://orcid.org/0000-0002-3886-8193"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"F. Boess","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: franziska.boess@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: franziska.boess@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110522374","display_name":"Connor McGinnis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"C. McGinnis","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: claudia.mcginnis@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: claudia.mcginnis@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054484314","display_name":"Andreas Brink","orcid":"https://orcid.org/0000-0001-6927-8252","observed_orcids":["https://orcid.org/0000-0001-6927-8252"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"A. Brink","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: andreas.brink@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: andreas.brink@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090758757","display_name":"R. Lieven","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"R. Lieven","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: rebecca.lieven@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: rebecca.lieven@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047117438","display_name":"Stephen M. Fowler","orcid":"https://orcid.org/0000-0001-7331-3559","observed_orcids":["https://orcid.org/0000-0001-7331-3559"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"S. Fowler","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: stephen.fowler@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: stephen.fowler@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080567721","display_name":"Kuresh A. Youdim","orcid":"https://orcid.org/0000-0002-1072-1130","observed_orcids":["https://orcid.org/0000-0002-1072-1130"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"K. Youdim","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: kuresh.youdim@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":"https://orcid.org/0000-0002-1072-1130","affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: kuresh.youdim@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102932155","display_name":"Mohammed Ullah","orcid":"https://orcid.org/0000-0003-3263-983X","observed_orcids":["https://orcid.org/0000-0003-3263-983X"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"M. Ullah","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: mohammed.ullah@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: mohammed.ullah@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012075669","display_name":"Michaela Marschmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"M. Marschmann","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: michaela.marschmann@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: michaela.marschmann@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018550087","display_name":"Christine Zihlmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"C. Zihlmann","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: christine.zihlmann@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: christine.zihlmann@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026971480","display_name":"Yves Siegrist","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Y.M. Siegrist","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: yves_martin.siegrist@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: yves_martin.siegrist@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053642156","display_name":"Anne\u2010Christine Cascais","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"A.C. Cascais","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: anne-christine.cascais@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: anne-christine.cascais@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010830739","display_name":"Elisa Di Lenarda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"E. Di Lenarda","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: elisa.di_lenarda@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: elisa.di_lenarda@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026219789","display_name":"Evelyne Durr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"E. Durr","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: evelyne.durr@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: evelyne.durr@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109061945","display_name":"N Schaub","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"N. Schaub","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: nathalie.schaub@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: nathalie.schaub@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028777103","display_name":"Xiaoman Ang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"X. Ang","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076225133","display_name":"Volkmar Starke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"V. Starke","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: volkmar.starke@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: volkmar.starke@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":null,"display_name":"T. Singer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"T. Singer","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: thomas.singer@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: thomas.singer@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035087051","display_name":"Rub\u00e9n Alvarez\u2010S\u00e1nchez","orcid":"https://orcid.org/0000-0001-7035-8022","observed_orcids":["https://orcid.org/0000-0001-7035-8022"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"R. Alvarez-Sanchez","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: ruben.alvarez_sanchez@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: ruben.alvarez_sanchez@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057418067","display_name":"Adrian B. Roth","orcid":"https://orcid.org/0000-0003-3164-3300","observed_orcids":["https://orcid.org/0000-0003-3164-3300"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"A.B. Roth","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: adrian_b.roth@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: adrian_b.roth@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040037974","display_name":"Franz Schuler","orcid":"https://orcid.org/0000-0001-5646-2149","observed_orcids":["https://orcid.org/0000-0001-5646-2149"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"F. Schuler","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: franz.schuler@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: franz.schuler@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001393185","display_name":"Christoph Funk","orcid":"https://orcid.org/0000-0001-7388-4415","observed_orcids":["https://orcid.org/0000-0001-7388-4415"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"C. Funk","raw_affiliation_strings":["Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: christoph.funk@roche.com","Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland. Electronic address: christoph.funk@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Grenzacher Str. 124, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5001393185"],"corresponding_institution_ids":["https://openalex.org/I118019719"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":7.9524,"has_fulltext":false,"cited_by_count":97,"citation_normalized_percentile":{"value":0.98920901,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"30","issue":"1","first_page":"429","last_page":"437"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-induced-liver-injury","display_name":"drug-induced liver injury","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-safety-assessment","display_name":"drug safety assessment","score":0.5659999847412109},{"id":"https://openalex.org/keywords/drug-candidates","display_name":"drug candidates","score":0.6809999942779541},{"id":"https://openalex.org/keywords/cyp3a4-inhibition","display_name":"CYP3A4 inhibition","score":0.8009999990463257},{"id":"https://openalex.org/keywords/glutathione-adducts","display_name":"glutathione adducts","score":0.8080000281333923},{"id":"https://openalex.org/keywords/mitochondrial-toxicity","display_name":"mitochondrial toxicity","score":0.984000027179718},{"id":"https://openalex.org/keywords/hepatocyte-toxicity","display_name":"hepatocyte cytotoxicity","score":0.8980000019073486},{"id":"https://openalex.org/keywords/fibroblast-cytotoxicity","display_name":"fibroblast cytotoxicity","score":0.8109999895095825},{"id":"https://openalex.org/keywords/dose-calibration","display_name":"dose calibration","score":0.4009999930858612},{"id":"https://openalex.org/keywords/drug-withdrawal","display_name":"drug withdrawal","score":0.3540000021457672}],"concepts":[{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.7552781105041504},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5574399828910828},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5158223509788513},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.49205201864242554},{"id":"https://openalex.org/C2776637226","wikidata":"https://www.wikidata.org/wiki/Q6658207","display_name":"Liver injury","level":2,"score":0.41145703196525574},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.34680092334747314},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3359867334365845},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15156340599060059}],"mesh":[{"descriptor_ui":"D000074020","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 11","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002138","descriptor_name":"Calibration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D005978","descriptor_name":"Glutathione","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018528","descriptor_name":"ATP-Binding Cassette Transporters","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D041681","descriptor_name":"NIH 3T3 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.tiv.2015.09.019","doi":"https://doi.org/10.1016/j.tiv.2015.09.019","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.tiv.2015.09.019","pdf_url":null,"source":{"id":"https://openalex.org/S39580544","display_name":"Toxicology in Vitro","issn_l":"0887-2333","issn":["0887-2333","1879-3177"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology in Vitro","raw_type":"journal-article"},{"id":"pmid:26407524","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26407524","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology in vitro : an international journal published in association with BIBRA","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W119625750","https://openalex.org/W1538990856","https://openalex.org/W1979392432","https://openalex.org/W1992890364","https://openalex.org/W1999418019","https://openalex.org/W1999587831","https://openalex.org/W2021580498","https://openalex.org/W2023922443","https://openalex.org/W2042221694","https://openalex.org/W2049789320","https://openalex.org/W2073730215","https://openalex.org/W2078543981","https://openalex.org/W2087561463","https://openalex.org/W2099064181","https://openalex.org/W2104209550","https://openalex.org/W2104910538","https://openalex.org/W2105668214","https://openalex.org/W2108234675","https://openalex.org/W2114457939","https://openalex.org/W2116209691","https://openalex.org/W2124428389","https://openalex.org/W2131594279","https://openalex.org/W2134837921","https://openalex.org/W2139049219","https://openalex.org/W2140427118","https://openalex.org/W2152548885","https://openalex.org/W2156466311","https://openalex.org/W2162401151","https://openalex.org/W2302091022","https://openalex.org/W2312617770","https://openalex.org/W3191473969"],"related_works":["https://openalex.org/W7220465212","https://openalex.org/W3033626309","https://openalex.org/W2998115089","https://openalex.org/W2599336749","https://openalex.org/W3011921139","https://openalex.org/W2792697385","https://openalex.org/W4281715003","https://openalex.org/W4407931300","https://openalex.org/W4411077313","https://openalex.org/W7143929854"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1790779685","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
